- Home
- DAWN vs CNEY Comparison
DAWN vs CNEY Comparison
Compare DAWN & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- CNEY
- Stock Information
- Founded
- DAWN 2018
- CNEY 2018
- Country
- DAWN United States
- CNEY China
- Employees
- DAWN N/A
- CNEY N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- CNEY Major Chemicals
- Sector
- DAWN Health Care
- CNEY Industrials
- Exchange
- DAWN Nasdaq
- CNEY Nasdaq
- Market Cap
- DAWN 1.3B
- CNEY 1.0M
- IPO Year
- DAWN 2021
- CNEY 2021
- Fundamental
- Price
- DAWN $12.57
- CNEY $0.33
- Analyst Decision
- DAWN Strong Buy
- CNEY
- Analyst Count
- DAWN 7
- CNEY 0
- Target Price
- DAWN $36.17
- CNEY N/A
- AVG Volume (30 Days)
- DAWN 1.0M
- CNEY 9.7M
- Earning Date
- DAWN 10-30-2024
- CNEY 01-01-0001
- Dividend Yield
- DAWN N/A
- CNEY N/A
- EPS Growth
- DAWN N/A
- CNEY N/A
- EPS
- DAWN N/A
- CNEY N/A
- Revenue
- DAWN $101,953,000.00
- CNEY $66,509,375.00
- Revenue This Year
- DAWN N/A
- CNEY N/A
- Revenue Next Year
- DAWN $36.10
- CNEY N/A
- P/E Ratio
- DAWN N/A
- CNEY N/A
- Revenue Growth
- DAWN N/A
- CNEY 35.10
- 52 Week Low
- DAWN $11.94
- CNEY $0.26
- 52 Week High
- DAWN $18.07
- CNEY $2.25
- Technical
- Relative Strength Index (RSI)
- DAWN 38.87
- CNEY 44.75
- Support Level
- DAWN $12.43
- CNEY $0.27
- Resistance Level
- DAWN $13.03
- CNEY $0.33
- Average True Range (ATR)
- DAWN 0.46
- CNEY 0.03
- MACD
- DAWN 0.03
- CNEY 0.01
- Stochastic Oscillator
- DAWN 36.33
- CNEY 34.05
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.